The global Lipid Nanoparticles (LNP) market was valued at US$ 600.1 million in 2023 and is projected to reach US$ 962.8 million by 2030, at a CAGR of 7.0% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
LNPs are liposome-like structures especially geared towards encapsulating a broad variety of nucleic acids (RNA and DNA); and as such, they are the most popular non-viral gene delivery system. Exelead develops and manufactures LNPs to encapsulate different types of genetic payloads including siRNA, mRNA and saRNA.
This report aims to provide a comprehensive presentation of the global market for Lipid Nanoparticles (LNP), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Lipid Nanoparticles (LNP). This report contains market size and forecasts of Lipid Nanoparticles (LNP) in global, including the following market information:
- Global Lipid Nanoparticles (LNP) Market Revenue, 2018-2023, 2024-2030, ($ millions)
- Global top five companies in 2023 (%)
The world's core manufacturers of Lipid Nanoparticles include Merck KGaA and others. The largest manufacturer has approximately 70% of the market share. North America is the world's largest market, accounting for approximately 60% of the market, followed by Europe and Asia Pacific, accounting for 26% and 9%, respectively. Among them, mRNA-lipid nanoparticles and siRNA-lipid nanoparticles accounted for 93% and 5%, respectively. The most used are vaccine drugs and scientific research, accounting for 81% and 19% respectively.
We surveyed the Lipid Nanoparticles (LNP) companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Lipid Nanoparticles (LNP) Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Lipid Nanoparticles (LNP) Market Segment Percentages, by Type, 2023 (%)
- mRNA-lipid Nanoparticle
- siRNA-lipid Nanoparticle
- Others
Global Lipid Nanoparticles (LNP) Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Lipid Nanoparticles (LNP) Market Segment Percentages, by Application, 2023 (%)
- Vaccines and Drugs
- Scientific Research
Global Lipid Nanoparticles (LNP) Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Lipid Nanoparticles (LNP) Market Segment Percentages, By Region and Country, 2023 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Lipid Nanoparticles (LNP) revenues in global market, 2018-2023 (estimated), ($ millions)
- Key companies Lipid Nanoparticles (LNP) revenues share in global market, 2023 (%)
key players include:
- Precision NanoSystems
- Evonik
- Merck KGaA
- Genevant Sciences
- Exelead
- Avanti Polar Lipids
- Nippon Fine Chemical
- Lipoid
- Including or excluding key companies relevant to your analysis.
Outline of Major Chapters:
Chapter 1: Introduces the definition of Lipid Nanoparticles (LNP), market overview.
Chapter 2: Global Lipid Nanoparticles (LNP) market size in revenue.
Chapter 3: Detailed analysis of Lipid Nanoparticles (LNP) company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Lipid Nanoparticles (LNP) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
